| $385M | ||
| $350M | ||
| $215M | ||
| $100M | ||
| $83M | ||
| $63M |
Buys | $0 | 0 | 0 |
Sells | $54,527,620 | 25 | 100 |
| GREENBERG LON R | director | 0 | $0 | 1 | $837,150 | $-837,150 |
| Campbell Elizabeth S | Executive Vice President | 0 | $0 | 2 | $1.74M | $-1.74M |
| Battaglia Silvana | Executive Vice President | 0 | $0 | 2 | $1.79M | $-1.79M |
| Krikorian Lazarus | SVP & Chief Accounting Officer | 0 | $0 | 2 | $2.25M | $-2.25M |
| Mauch Robert P. | President & CEO | 0 | $0 | 12 | $17.67M | $-17.67M |
| COLLIS STEVEN H | Executive Chairman | 0 | $0 | 6 | $30.24M | $-30.24M |
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Over the last 12 months, insiders at Cencora, Inc. have bought $0 and sold $54.53M worth of Cencora, Inc. stock.
On average, over the past 5 years, insiders at Cencora, Inc. have bought $109,290 and sold $808.28M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 500 shares for transaction amount of $109,290 was made by DURCAN DERMOT MARK (director) on 2024‑05‑24.
| 2026-02-20 | Sale | Mauch Robert P. | President & CEO | 3,762 0.0019% | $358.94 | $1.35M | -8.74% | |
| 2026-02-18 | Sale | Mauch Robert P. | President & CEO | 1,333 0.0007% | $359.46 | $479,160 | -8.26% | |
| 2026-01-20 | Sale | Mauch Robert P. | President & CEO | 5,096 0.0027% | $354.73 | $1.81M | +0.41% | |
| 2025-12-19 | Sale | Campbell Elizabeth S | Executive Vice President | 3,351 0.0017% | $342.10 | $1.15M | +2.70% | |
| 2025-12-19 | Sale | Battaglia Silvana | Executive Vice President | 1,677 0.0009% | $345.00 | $578,565 | +2.70% | |
| 2025-12-18 | Sale | Mauch Robert P. | President & CEO | 5,096 0.0027% | $343.45 | $1.75M | +2.74% | |
| 2025-12-17 | Sale | Krikorian Lazarus | SVP & Chief Accounting Officer | 4,031 0.0021% | $343.24 | $1.38M | +1.49% | |
| 2025-11-18 | Sale | Mauch Robert P. | President & CEO | 5,096 0.0027% | $366.64 | $1.87M | -3.76% | |
| 2025-10-20 | Sale | Mauch Robert P. | President & CEO | 5,097 0.0026% | $326.80 | $1.67M | +5.91% | |
| 2025-10-01 | Sale | Campbell Elizabeth S | Executive Vice President | 1,886 0.001% | $313.28 | $590,846 | +9.86% | |
| 2025-09-18 | Sale | Mauch Robert P. | President & CEO | 5,097 0.0026% | $290.00 | $1.48M | +17.37% | |
| 2025-09-16 | Sale | COLLIS STEVEN H | Executive Chairman | 31,350 0.0162% | $289.86 | $9.09M | +17.66% | |
| 2025-08-19 | Sale | COLLIS STEVEN H | Executive Chairman | 14,579 0.0074% | $289.98 | $4.23M | +15.30% | |
| 2025-08-18 | Sale | Mauch Robert P. | President & CEO | 4,968 0.0026% | $293.53 | $1.46M | +16.90% | |
| 2025-07-22 | Sale | COLLIS STEVEN H | Executive Chairman | 14,578 0.0075% | $292.67 | $4.27M | +14.89% | |
| 2025-07-18 | Sale | Mauch Robert P. | President & CEO | 4,968 0.0026% | $294.11 | $1.46M | +14.86% | |
| 2025-06-24 | Sale | COLLIS STEVEN H | Executive Chairman | 14,579 0.0075% | $292.62 | $4.27M | +12.01% | |
| 2025-06-18 | Sale | Mauch Robert P. | President & CEO | 4,969 0.0026% | $295.30 | $1.47M | +10.80% | |
| 2025-06-18 | Sale | Battaglia Silvana | Executive Vice President | 4,077 0.0021% | $297.40 | $1.21M | +10.80% | |
| 2025-05-29 | Sale | Krikorian Lazarus | SVP & Chief Accounting Officer | 3,000 0.0015% | $288.96 | $866,881 | +11.35% |
| COLLIS STEVEN H | Executive Chairman | 305913 0.1573% | $100.2M | 0 | 18 | |
| Mauch Robert P. | President & CEO | 65393 0.0336% | $21.42M | 0 | 15 | |
| Campbell Elizabeth S | Executive Vice President | 23891 0.0123% | $7.83M | 0 | 4 | |
| Battaglia Silvana | Executive Vice President | 18796 0.0097% | $6.16M | 0 | 5 | |
| GREENBERG LON R | director | 17851 0.0092% | $5.85M | 0 | 1 | |
| Krikorian Lazarus | SVP & Chief Accounting Officer | 17154 0.0088% | $5.62M | 0 | 4 | |
| Walgreens Boots Alliance, Inc. | 10 percent owner | 12570000 6.4617% | $4.12B | 0 | 4 | |
| Szurek Paul E. | President & CEO | 242347 0.1246% | $79.38M | 3 | 13 | +9.75% |
| COLEMAN JAMES H | Sr. VP, Business Development | 200397 0.103% | $65.64M | 1 | 0 | <0.0001% |
| STOLL ROGER G PHD | Chief Executive Officer | 100000 0.0514% | $32.76M | 7 | 0 | <0.0001% |
| DRAKE PETER F | director | 50000 0.0257% | $16.38M | 1 | 0 | <0.0001% |
| Rockwood Robert K. | SVP, General Management | 39868 0.0205% | $13.06M | 0 | 7 | |
| STAPLE PETER D | President & CEO | 34878 0.0179% | $11.42M | 2 | 0 | +14.17% |
| ALLNUTT ROBERT | director | 30000 0.0154% | $9.83M | 1 | 0 | +9.79% |
| Tran Pierre V | Chief Medical Officer | 30000 0.0154% | $9.83M | 1 | 0 | <0.0001% |
| TOLLEFSON GARY D | director | 28000 0.0144% | $9.17M | 1 | 0 | <0.0001% |
| Warren Brian | SVP, Engineering & Product | 25121 0.0129% | $8.23M | 0 | 36 | |
| Tobin Dominic M. | SVP, Operations | 23892 0.0123% | $7.83M | 2 | 28 | +22.52% |
| DURCAN DERMOT MARK | director | 21876 0.0112% | $7.17M | 1 | 0 | +9.56% |
| Dunn David W. | SVP, Mergers and Acquisitions | 19171 0.0099% | $6.28M | 1 | 1 | +21.46% |
| MESSINGER MARIA S | Chief Financial Officer | 15000 0.0077% | $4.91M | 1 | 0 | <0.0001% |
| Hatzenbuehler Anthony | SVP, Field Operations | 13639 0.007% | $4.47M | 0 | 5 | |
| Clark Gina | Executive Vice President | 13284 0.0068% | $4.35M | 0 | 4 | |
| Bair Christopher M. | SVP, Sales and Leasing | 11525 0.0059% | $3.78M | 1 | 1 | +5.42% |
| Price Chuck D. | SVP, Information Technology | 9556 0.0049% | $3.13M | 1 | 0 | +21.88% |
| Thompson John David | director | 8629 0.0044% | $2.83M | 1 | 1 | +23.17% |
| Carlyle Realty III, GP, L.L.C. | 10 percent owner | 0 0% | $0 | 0 | 8 | |
| Carlyle Realty V GP, L.L.C. | 10 percent owner | 0 0% | $0 | 0 | 2 | |
| CRP IV AIV GP, L.L.C. | 10 percent owner | 0 0% | $0 | 0 | 8 | |
| Carlyle Group Management L.L.C. | 10 percent owner | 0 0% | $0 | 0 | 9 |
$2,815,172 | 70 | -41.50% | $4.7M | |
Cencora (COR) | $1,022,434 | 25 | 5.12% | $63.72B |
| Increased Positions | 732 | +48.35% | 17M | +9.02% |
| Decreased Positions | 648 | -42.8% | 18M | -9.18% |
| New Positions | 216 | New | 2M | New |
| Sold Out Positions | 95 | Sold Out | 3M | Sold Out |
| Total Postitions | 1,598 | +5.55% | 192M | -0.16% |
| Vanguard Group Inc | $7.93M | 12.06% | 23.4M | +916,506 | +4.08% | 2025-09-30 |
| Blackrock, Inc. | $6.7M | 10.2% | 19.78M | +1M | +5.74% | 2025-09-30 |
| State Street Corp | $3.11M | 4.74% | 9.19M | +782,911 | +9.31% | 2025-09-30 |
| Price T Rowe Associates Inc /Md/ | $2.62M | 3.98% | 7.72M | -70,668 | -0.91% | 2025-09-30 |
| Walgreens Boots Alliance, Inc. | $2.53M | 3.85% | 7.47M | -3M | -28.01% | 2025-06-30 |
| Geode Capital Management, Llc | $1.79M | 2.73% | 5.29M | +502,812 | +10.5% | 2025-09-30 |
| Jpmorgan Chase & Co | $1.59M | 2.41% | 4.68M | +771,198 | +19.74% | 2025-09-30 |
| Boston Partners | $1.53M | 2.32% | 4.51M | +89,506 | +2.02% | 2025-09-30 |
| Invesco Ltd. | $1.36M | 2.07% | 4.01M | -31,769 | -0.79% | 2025-09-30 |
| Wellington Management Group Llp | $1.35M | 2.05% | 3.97M | +115,278 | +2.99% | 2025-09-30 |